Leap Therapeutics Inc. buy BiotechBee
Start price
07.01.24
/
50%
€3.70
Target price
30.09.25
€5.00
Performance (%)
-27.03%
End price
14.12.24
€2.70
Summary
This prediction ended on 14.12.24 with a price of €2.70. The prediction for Leap Therapeutics Inc. disappointed with a performance of -27.03%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Leap Therapeutics Inc. | -4.712% | -4.712% | -72.086% |
| iShares Core DAX® | 2.331% | 5.140% | 25.000% |
| iShares Nasdaq 100 | 2.077% | 2.956% | 8.935% |
| iShares Nikkei 225® | 2.759% | 7.214% | 22.171% |
| iShares S&P 500 | 1.613% | 2.893% | 6.249% |
According to BiotechBee what are the pros and cons of Leap Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year